Google Chrome
Safari
Firefox
Edge
News / Jul 10, 2017
FDA Training at Hovione New Jersey Site
Hovione New Jersey welcomes a team of 8 FDA Reviewers for a training on Quality by Design (QbD)
Search
Dispersome®
Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.
Press Release / Jun 18, 2024
Hovione Unveils New Continuous Tableting Line at Lisbon R&D Centre
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
Press Clipping / Oct 28, 2025
Oct. 28 Business Watch: More plants closing in Europe, Novartis to pay $12 billion for biotech firm
C&EN, 28 October 2025
Press Release / Oct 29, 2007
FDA inspects Hovione’s Technology Transfer Center in New Jersey
Press Release / Oct 17, 2018
Hovione increases production capacity
‘One Site Shop’ expands to respond to growing demands
Press Clipping / Jun 21, 2021
Hovione meets increased demand during Covid
Irish Examiner, 21 june 2021